γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct.

Titleγ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct.
Publication TypeJournal Article
Year of Publication2017
AuthorsRan Y, Hossain F, Pannuti A, Lessard CB, Ladd GZ, Jung JI, Minter LM, Osborne BA, Miele L, Golde TE
Journal{EMBO} Molecular Medicine
Volume9
Pagination950–966
Date Publishedmay
URLhttps://doi.org/10.15252/emmm.201607265
DOI10.15252/emmm.201607265